Balance Motif Vape Pod 1mL - Pennywise (PW)
Rated as high potency.
Parents: Harlequin, Jack the Ripper
Effects: Relaxed, Sleepy, Happy, Euphoric, Focused, Uplifted
Flavors: Pepper, Coffee, Pine, Woody, Citrus, Earthy
Pennywise is our signature Balance strain that is grown for its THC/CBD Content.
Pennywise is available in an Etain Balance 1:1 Motif Pod in .5mL and 1mL and is created by crossing the strains Harlequin x Jack the Ripper.
Pennywise contains a 1:1 ratio of CBD and THC, so the psychoactive effects are milder and more relaxing. After consuming this strain, patients have reported a mild cerebral high and an improvement in mood.
High CBD strains have shown potential in alleviating the effects of PTSD, arthritis, epilepsy and various neurological disorders. These kinds of strains have also been observed to have neuroprotective properties. Pennywise’s generally sedate mood can potentially help relieve stress and calm anxiety.
New York's Only Women-Founded Medical Cannabis Business
Etain is a family-run, women-founded medical cannabis business committed to manufacturing clean, safe, and consistent medical cannabis products for the patients of New York State. Etain, LLC is a registered organization providing medical cannabis products under the New York Compassionate Care Act enacted July, 2014 by Governor Andrew M. Cuomo.
What We Do
We cultivate, manufacture, and dispense the highest-quality medical cannabis products available on the market. We give patients safe, legal access to palliative medicines for effective treatment of debilitating symptoms and diseases. With dispensary locations in Syracuse, New York City, Kingston, and Yonkers we’re providing compassionate care to the citizens of New York State.
Our Mission
Our mission is to improve the quality of life for patients in New York State by providing access to the highest quality, pharmaceutical-grade medical cannabis treatments available. Further, we are committed to research, discovery, and advocacy in pursuit of healthy solutions for diseases, conditions, and the management of debilitating symptoms for patients everywhere.
